Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus

Background: Sclerostin has been associated with decreased bone turnover in patients with type 2 diabetes mellitus (T2DM). The relationship with bone turnover markers (BTMs) and bone mineral density (BMD) remains unclear. We investigate the relationship between total and bioactive sclerostin measured...

Full description

Saved in:
Bibliographic Details
Main Authors: Cyril Traechslin, Lilian Sewing, Sandra Baumann, Leticia Grize, Janina Vavanikunnel, Marius Kraenzlin, Christoph Henzen, Christian Meier
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623725000110
Tags: Add Tag
No Tags, Be the first to tag this record!